Almazov National Medical Research Centre

Saint Petersburg 197341

2 studies enrolling now · 10 studies all time

What they study most

Acromegaly, Coronary Heart Disease (CHD), Graft Vs Host Disease, Heart Failure With Left Bundle Branch Block, Leukemia, B-cell, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Primary Myelofibrosis (PMF), Severe Hypertriglyceridemia, Solid Tumor

Studies at this site

• Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
• Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD) — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. — Running, not enrolling
• AdaptResponse Clinical Trial — Completed
• Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function — Completed
• Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment — Completed
• Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis — Status unconfirmed